SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    Form 8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                      Securities Exchange Act of 1934 Date
                        of Report (Date of earliest event
                           reported): August 22, 2006

                              Scantek Medical, Inc.
   --------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)


       Delaware                      000-27592                84-1090126
--------------------------------------------------------------------------------
(State or other jurisdiction       (Commission             (IRS Employer
    of incorporation)              File Number)          Identification No.)


               4B Wing Drive, Cedar Knolls, NJ 07927
--------------------------------------------------------------------------------
               (Address of principal executive offices) (Zip Code)

     Registrant's telephone number, including area code         (973) 401-0434


--------------------------------------------------------------------------------
         (Former name or former address, if changed since last report.)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

|_|   Written  communications  pursuant to Rule 425 under the Securities Act (17
      CFR 230.425)

|_|   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)

|_|   Pre-commencement  communications  pursuant  to  Rule  14d-2(b)  under  the
      Exchange Act (17 CFR 240.14d-2(b))

|_|   Pre-commencement  communications  pursuant  to  Rule  13e-4(c)  under  the
      Exchange Act (17 CFR 240.13e-4(c))


                                      -1-
<PAGE>

Section 1 -- Registrant's Business and Operations
Item 1.01 Entry into a Material Definitive Agreement.

On August 22, 2006, Scantek Medical,  Inc. ("Scantek") entered into an agreement
(the  "Amended  Agreement")  which  amended and  restated  its  December 3, 2004
Definitive Agreement with Life Medical Technologies, Inc. ("Life Medical").

Scantek has announced the Amended  Agreement in a press release dated  September
6, 2006, which press release provides details not included in previously  issued
reports.  A copy of the press release is furnished  with this Current  Report on
Form 8-K as Exhibit 99.1. A copy of the Amended Agreement is furnished with this
Current Report on Form 8-K as Exhibit 99.2.

Section 7 --Regulation FD
Item 7.01 Regulation FD Disclosure.

The  information  disclosed  above  in  Item  1.01  is  incorporated  herein  by
reference.

Section 9 - Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits.

Exhibit No. Description

99.1        Press Release of Scantek Medical, Inc. dated September 6, 2006.

99.2        Definitive  Agreement between Scantek and Life Medical,  dated as of
            the 3rd day of December, 2004, as amended on the 22nd day of August,
            2006.

                                   SIGNATURES

      Pursuant to the  requirements of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                  Scantek Medical, Inc.

Date: September 6, 2006           By: /s/ Zsigmond L. Sagi
                                      --------------------------------
                                      Dr. Zsigmond Sagi, President

                                      -2-
{"company-data": {"conformed-name": "SCANTEK MEDICAL INC", "cik": "0000926229", "assigned-sic": "5047", "irs-number": "841090126", "state-of-incorporation": "DE", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-28824", "film-number": "061079467"}, "business-address": {"street1": "321 PALMER ROAD", "city": "DENVILLE", "state": "NJ", "zip": "079834", "phone": "9733665250"}, "mail-address": {"street1": "321 PALMER ROAD", "city": "DENVILLE", "state": "NJ", "zip": "07834"}}
SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    Form 8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                      Securities Exchange Act of 1934 Date
                        of Report (Date of earliest event
                           reported): August 22, 2006

                              Scantek Medical, Inc.
   --------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)

       Delaware                      000-27592                84-1090126
--------------------------------------------------------------------------------
(State or other jurisdiction       (Commission             (IRS Employer
    of incorporation)              File Number)          Identification No.)

               4B Wing Drive, Cedar Knolls, NJ 07927
--------------------------------------------------------------------------------
               (Address of principal executive offices) (Zip Code)

     Registrant's telephone number, including area code         (973) 401-0434

--------------------------------------------------------------------------------
         (Former name or former address, if changed since last report.)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

|_|   Written  communications  pursuant to Rule 425 under the Securities Act (17
      CFR 230.425)

|_|   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)

|_|   Pre-commencement  communications  pursuant  to  Rule  14d-2(b)  under  the
      Exchange Act (17 CFR 240.14d-2(b))

|_|   Pre-commencement  communications  pursuant  to  Rule  13e-4(c)  under  the
      Exchange Act (17 CFR 240.13e-4(c))

                                      -1-
Section 1 -- Registrant's Business and Operations
Item 1.01 Entry into a Material Definitive Agreement.

On August 22, 2006, Scantek Medical,  Inc. ("Scantek") entered into an agreement
(the  "Amended  Agreement")  which  amended and  restated  its  December 3, 2004
Definitive Agreement with Life Medical Technologies, Inc. ("Life Medical").

Scantek has announced the Amended  Agreement in a press release dated  September
6, 2006, which press release provides details not included in previously  issued
reports.  A copy of the press release is furnished  with this Current  Report on
Form 8-K as Exhibit 99.1. A copy of the Amended Agreement is furnished with this
Current Report on Form 8-K as Exhibit 99.2.

Section 7 --Regulation FD
Item 7.01 Regulation FD Disclosure.

The  information  disclosed  above  in  Item  1.01  is  incorporated  herein  by
reference.

Section 9 - Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits.

Exhibit No. Description

99.1        Press Release of Scantek Medical, Inc. dated September 6, 2006.

99.2        Definitive  Agreement between Scantek and Life Medical,  dated as of
            the 3rd day of December, 2004, as amended on the 22nd day of August,
            2006.

                                   SIGNATURES

      Pursuant to the  requirements of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                  Scantek Medical, Inc.

Date: September 6, 2006           By: /s/ Zsigmond L. Sagi
                                      --------------------------------
                                      Dr. Zsigmond Sagi, President

                                      -2-